Jade Biosciences, Inc. Earnings Per Share Diluted

Quick Answer

Jade Biosciences, Inc. reported Earnings Per Share Diluted of $3.19 (loss) per share for the year ending 2025.

  • Jade Biosciences, Inc. showed a decrease of -30.7% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Jade Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 6, 2026.
  • XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2021 to 2025), Jade Biosciences, Inc.'s Earnings Per Share Diluted has declined by 70.6%.
  • Historical annual values: Fiscal year 2025: $3.19 (loss) per share | Fiscal year 2024: $2.44 (loss) per share | Fiscal year 2023: $2.87 (loss) per share | Fiscal year 2022: $2.10 (loss) per share | Fiscal year 2021: $1.87 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: